Predictive factors of restenosis: What changes with «active» stents?;Les facteurs prédictifs de la resténose: Quels changements avec les stents «actifs»?

Pathologie Biologie

Volumn 52, Issue 4, 2004, Pages 206-211

  Schiele, F ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Active stent; Angioplastie; Angioplasty; Restenosis; Rest nose; Revascularisation; Stent actif

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; ARTERY DIAMETER; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; HUMAN; INTRAVASCULAR ULTRASOUND; PREDICTION; RESTENOSIS; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 2442484779     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.01.013     Document Type: Article

References (37)

1. Kimura T., Nosaka H., Yokoi H., Iwabuchi M., Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol. 21:1993;1557-1563
2. Serruys P.W., Luijten H.E., Beatt K.J., Geuskens R., de Feyter P.J., van den Brand M., et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 77:1988;361-371
3. Holmes D., Vlietstra R., Smith H., Vetrovec G., Kent K., Cowley M.J., et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA). A report from the PTCA registry of the National Heart, Lungs and Blood Institutes. Am j Cardiol. 53:1984;77C-81C
4. Thornton M., Gruentzig A., Hollmann J., King S.B., Douglas J.S. Jr. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation. 69:1984;721-727
5. Schomig A., Kastrati A., Elezi S., Schuhlen H., Dirschinger J., Dannegger F., Wilhelm M., Ulm K. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. Circulation. 96:1997;3880-3887
6. Weintraub W.S., Kosinski A.S., Brown C.L.D., King S.B.D. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 21:1993;6-14
7. Kastrati A., Schomig A., Elezi S., Schuhlen H., Dirschinger J., Hadamitzky M., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 30:1997;1428-1436
8. Serruys P.W., Kay I.P., Disco C., Deshpande N.V., de Feyter P.J. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol. 34:1999;1067-1074
9. de Feyter P.J., Kay P., Disco C., Serruys P.W. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation. 100:1999;1777-1783
10. Rensing B.J., Hermans W.R., Vos J., Tijssen J.G., Rutch W., Danchin N., et al. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation. 88:1993;975-985. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group
11. Van Belle E., Bauters C., Hubert E., Bodart J.C., Abolmaali K., Meurice T., et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation. 96:1997;1454-1460
12. Carrozza J.P. Jr, Kuntz R.E., Fishman R.F., Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 118:1993;344-349
13. Kasaoka S., Tobis J.M., Akiyama T., Reimers B., Di Mario C., Wong N.D., Colombo A. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol. 32:1998;1630-1635
14. de Groote P., Bauters C., McFadden E.P., Lablanche J.M., Leroy F., Bertrand M.E. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty. Circulation. 91:1995;968-972
15. Amant C., Bauters C., Bodart J.C., Lablanche J.M., Grollier G., Danchin N., et al. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 96:1997;56-60
16. Kastrati A., Schomig A., Seyfarth M., Koch W., Elezi S., Bottiger C., et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation. 99:1999;1005-1010
17. Foley D.P., Melkert R., Serruys P.W. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 90:1994;1239-1251
18. Wong S.C., Baim D.S., Schatz R.A., Teirstein P.S., King S.B. 3rd, Curry R.C. Jr, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter US Palmaz-Schatz stent experience. J Am Coll Cardiol. 26:1995;704-712. The Palmaz-Schatz Stent Study Group
19. Bauters C., Banos J.L., Van Belle E., Mc Fadden E.P., Lablanche J.M., Bertrand M.E. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation. 97:1998;318-321
20. Eltchaninoff H., Koning R., Tron C., Gupta V., Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol. 32:1998;980-984
21. Hoffmann R., Mintz G.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., et al. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol. 31:1998;43-49
22. Moussa I., di Mario C., Moses J., Di Francesco L., Reimers B., Tobis J., Colombo A. The impact of preintervention plaque area as determined by intravascular ultrasound on luminal renarrowing following coronary stenting. Circulation. 94:1996;I-261
23. Mudra H., Regar E., Klauss V., Werner F., Henneke K.H., Sbarouni E., Theisen K. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. Circulation. 95:1997;363-370
24. Schiele F., Meneveau N., Vuillemenot A., Zhang D.D., Gupta S., Mercier M., et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies - with and without intravascular ultrasound guidance. J Am Coll Cardiol. 32:1998;320-328. RESIST Study Group. REStenosis after Ivus guided STenting
25. Bruining N., Sabate M., de Feyter P.J., Kay I.P., Ligthart J., Disco C., et al. Quantitative measurements of in-stent restenosis: A comparison between quantitative coronary ultrasound and quantitative coronary angiography. Catheter Cardiovasc Interv. 48:1999;133-142
26. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495. Benestent Study Group
27. Serruys P.W., van Hout B., Bonnier H., Legrand V., Garcia E., Macaya C., et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 352:1998;673-681
28. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501. Stent Restenosis Study Investigators [see comments]
29. Oemrawsingh P.V., Mintz G.S., Schalij M.J., Zwinderman A.H., Jukema J.W., van der Wall E.E. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 107:2003;62-67
30. Cutlip D., Chauhan M., Baim D., Ho K., Popma J., Carrozza J.P., Cohen D., Kuntz R. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 40:2002;2082-2089
31. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780
32. Park S.J., Shim W.H., Ho D.S., Raizner A.E., Park S.W., Hong M.K., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 348:2003;1537-1545
33. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., et al. Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions. Circulation. 4:2003;4
34. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 100:1999;1872-1878
35. Kereiakes D.J. Hippocrates revisited: the evidence for drug-eluting stents. Circulation. 107:2003;3012-3014
36. Lemos P.A., Serruys P.W., Sousa J.E. Drug-eluting stents: cost vs clinical benefit. Circulation. 107:2003;3003-3007
37. O'Neill W.W., Leon M.B. Drug-eluting stents: costs vs clinical benefit. Circulation. 107:2003;3008-3011